Appili Therapeutics Brief: Also Noted Government Funding Committed to Enable Appili to Advance Its Biodefense Vaccine Candidate ATI-1701 Towards an IND
Appili Therapeutics Brief: Also Noted Government Funding Committed to Enable Appili to Advance Its Biodefense Vaccine Candidate ATI-1701 Towards an IND
Appili Therapeutics 簡報:還注意到政府承諾提供資金,使 Appili 能夠將其生物防禦疫苗候選疫苗 ATI-1701 推向新藥研發階段
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊